Imputation of assay bioactivity data using deep learning
This article describes a novel deep learning neural network method and its application for the imputation of bioactivity data, such…
Ground-breaking artificial intelligence software and services
Augmented Chemistry® technologies complement your research teams to guide effective drug discovery strategies
Augmented Chemistry, Optibrium’s approach to AI in drug discovery, complements the skills and knowledge of expert scientists. Augmented Chemistry’s unique AI methods learn the complex relationships between compound structures and data at a scale that is impossible for even the largest team of scientists, providing actionable results that guide research strategy.
- ‘Fill in the gaps’ in your database with confident results highlighting new opportunities and high-quality compounds
- Reduce synthetic and experimental costs by targeting the most valuable compounds and data to achieve your objectives
- Run virtual screens and guide design to find new, high-quality compounds for your projects
Peer reviewed
Powered by Alchemite, a deep learning method developed by Optibrium’s technology partner, Intellegens. In collaboration with pharmaceutical and biotechnology partners, Optibrium has rigorously demonstrated Alchemite’s unique benefits over conventional modelling methods in peer-reviewed studies, resulting in reductions in cost and time of discovery cycles.
Practical applications of deep learning to impute heterogeneous drug discovery data
This article outlines practical applications of deep learning on drug discovery data. It introduces some of the research behind our…
Cerella
Extract more value from your compound data, confidently target high-quality compounds and accelerate discovery cycles.
Cerella™ offers cloud-enabled deployment, scaling from individual projects to full corporate compound repositories, implementing multi-level security, fully under your control. Data are fully encrypted and anonymised in the cloud.
